IDH1 and neoplasm: Whereas none of the Mongolian HCC tumor samples was found to carry mutations in IDH1 or IDH2, we observed a subset of 9 samples in the Mongolian cohort that appears to carry TCGA’s IDH-like gene signature (Supplementary Fig. 8a).